Amica Mutual Insurance Co. significantly increased its stake in PepsiCo (NASDAQ:PEP) by 69.2% in the fourth quarter, bringing its total holdings to 31,346 shares valued at approximately $4.5 million. This increase follows PepsiCo's strong quarterly results, which surpassed analyst expectations for both EPS and revenue. The company also demonstrated a commitment to shareholder returns by raising its quarterly dividend and authorizing a $10 billion share repurchase program.

Amica Mutual Insurance Co. significantly increased its stake in Domino's Pizza Inc. (NASDAQ:DPZ) by 59.8% in the fourth quarter, bringing its total holdings to 16,576 shares valued at approximately $6.9 million. This acquisition comes as Domino’s recently reported Q1 earnings that missed analyst estimates, though revenue increased by 3.5% year over year. The company declared a quarterly dividend of $1.99 per share, and analysts currently have a mixed "Hold" rating with an average price target of $418.13.

Ellenbecker Investment Group increased its stake in Apple Inc. by 4.7% in the fourth quarter, bringing its total holdings to 38,676 shares valued at $10.5 million. Institutional ownership of Apple remains high at 67.73%, with analysts maintaining a generally positive outlook, citing potential growth from AI initiatives and strong earnings. Despite some insider selling, the company recently announced a small dividend increase and continues to trade near its 52-week high.

Fire Capital Management LLC increased its stake in Amazon.com, Inc. by 19.5% in the fourth quarter of the prior year, bringing its total holdings to 20,394 shares valued at approximately $4.7 million. Several other institutional investors also adjusted their positions in Amazon, with hedge funds and institutional investors collectively owning 72.2% of the stock. Analysts remain largely bullish on Amazon, raising price targets after strong earnings and momentum in AI and cloud services, despite some recent negative news regarding regulatory issues and AI spending concerns.

Bluebird Wealth Management LLC has invested $3.22 million in Amazon.com, Inc. by acquiring 13,960 shares, making it their fifth-largest holding. Institutional ownership of Amazon is high at 72.2%, with major firms increasing their positions. Analysts remain bullish on Amazon, reiterating "buy" ratings and raising price targets, citing strong growth in AWS and AI-related momentum.

BioRestorative Therapies has extended the employment agreements for its President, Chief Executive Officer, and Chairman of the Board, Lance Alstodt, and its Chief Financial Officer, Robert Kristal. Both agreements are effective through May 27, 2029, with their current salaries remaining unchanged at $600,000 for Alstodt and $350,000 for Kristal. The filings indicate no other changes to their roles or board positions.

Ford is offering various incentives on the Maverick compact pickup through July 6, including up to $3,000 in dealer cash for both 2025 and 2026 models, and a $1,000 consumer rebate for 2025 models. Low-interest financing at 2.9% for up to 36 months is available for 2025 Mavericks, along with regional lease deals. These incentives aim to boost sales for the popular and fuel-efficient Maverick, which is a significant success in the compact truck market.

Cullen Frost Bankers Inc. reduced its Meta Platforms (NASDAQ:META) holdings by 0.4% in the fourth quarter, selling 919 shares and maintaining 207,361 shares valued at approximately $136.9 million. Meta reported strong quarterly earnings, exceeding analyst expectations with $10.44 EPS and $56.31 billion in revenue, a 33.1% year-over-year increase. Despite recent insider selling and some lowered price targets, analysts largely maintain a "Moderate Buy" consensus with an average target price of $840.19.

The rise of agentic AI has caused fear among SaaS companies, leading to a decline in some stock values, including ServiceNow and Palantir. However, this article argues that these specific companies are well-positioned to thrive because their platforms, like ServiceNow's Control Tower and Palantir's AIP, are designed to manage and unify AI agents. Despite their strong growth and relevance in an AI-driven world, investors should approach with caution due to their high valuations.

Actinium Pharmaceuticals has announced the allowance of two new patents covering aspects of its Actimab-A and Iomab-ACT programs. These patent allowances strengthen the company's intellectual property for its radiopharmaceutical therapies. The news was promptly shared with Quantisnow Plus members.